2BB score and signals
Protara Therapeutics, Inc.’s current 2BB score is 52 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 65 | High |
| Momentum | 49 | Stable |
| Financial strength | 25 | Weak |
| Quality | 60 | Strong |
| Risk | 42 | Moderate |
2BBBullish & Bearish
Protara Therapeutics, Inc. (TARA) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 52 out of 100.
Protara Therapeutics, Inc.’s current 2BB score is 52 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 65 | High |
| Momentum | 49 | Stable |
| Financial strength | 25 | Weak |
| Quality | 60 | Strong |
| Risk | 42 | Moderate |
| Founded | 2006 |
| Employees | 46 |
| 52-week range | $2.97 – $7.82 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-09 | — | -0.3555 | — | $0.00 |
| 2026-07-30 | — | -0.3322 | — | $0.00 |
| 2026-05-13 | -0.31 | -0.3818 | $0.00 | $0.00 |
| 2026-02-24 | -0.37 | -0.3315 | $0.00 | $0.00 |